Monash IVF Group Ltd (ASX: MVF), a leading provider of assisted reproductive services (ARS) and specialist women’s imaging and diagnostic services in Australia and Malaysia, is pleased to announce the appointment of Mr David Morris as the CEO and MD effective from 13 November 2017.
David has more than 20 years of leadership, international business development and strategy experience. Over his 13 years at Cochlear Limited, the global leader in implantable hearing solutions, which includes cochlear implants, bone conduction implants and middle ear implants, David served as Chief Strategy Officer, having previously served as President of Cochlear Bone Anchored Solutions and as Senior Vice President of Business Development.
Prior to joining Cochlear Limited, David worked at Accenture in the strategy practice. David has extensive experience internationally and domestically in the healthcare, consumer products, utilities, and financial services industries.
David holds degrees in Business and Applied Science from Monash University, Melbourne Australia. He has also completed an Advanced Business Management Program at Kellogg School of Management, Northwestern University in Chicago, USA and is a graduate of the Australian Institute of Company Directors.
MVF Chairman Richard Davis said; “We are pleased to welcome someone with the nature of David’s experience in healthcare, international business development and strategy setting and execution. We are confident that his leadership, skills and experience will be of significant benefit at a time where we continue to explore strategic growth opportunities domestically and in global markets”.
MVF new CEO and MD David Morris said; “I am honoured and excited to be working in such an innovative company that is at the forefront of fertility treatment. I look forward to leading Monash IVF Group through its next phase of growth, and to building further on its local and international success.”
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.